HC restrains generic pharma firms from making, selling patent drug of Novartis, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The court’s order came on the plea by Novartis, represented through advocate Mamta Jha, seeking to restrain other pharma firms from manufacturing or selling the patented combination of Sacubitril and Valsartan tablets., The court’s order came on the plea by Novartis, represented through advocate Mamta Jha, seeking to restrain other pharma firms from manufacturing or selling the patented combination of Sacubitril and Valsartan tablets., , Read More

Leave a Reply

Your email address will not be published.